BackgroundLow vitamin D levels affects muscle function. Vitamin D and calcium deficiency cause osteomalacic myopathy and poor functional recovery after hip fractures. The relationship of vitamin D and functional performance after total knee arthroplasty (TKA) is not previously reported.MethodsInfluence of vitamin D on functional performance before and after TKA was reviewed retrospectively in 120 patients. Of these, 64 had vitamin D deficiency (25-hydroxy vitamin D < 30 ng/mL) preoperatively. All 120 patients received vitamin D oral supplementation postoperatively. Functional parameters including Western Ontario and McMaster Osteoarthritis Index (WOMAC), Short-Form Health Survey questionnaire, and Knee Society Score were assessed pre- and postoperatively at 3 months.ResultsPreoperative function was significantly lower in osteoarthritic patients with vitamin D deficiency (WOMAC score; p = 0.040), but at 3 months all functional scores were similar.ConclusionsWe concluded that vitamin D deficiency has a negative effect on function in knee osteoarthritic patients. However, postoperative vitamin D supplementation can lead to functional recovery in these patients. Thus, TKA should not be delayed in vitamin D deficient patients; rather supplementation in the postoperative period is preferable to achieve comparable functional outcome at 3 months to patients with vitamin D sufficiency.
BackgroundNo study in the literature has compared early functional recovery following total knee arthroplasty (TKA) in the obese with the nonobese using World Health Organization (WHO) classes of obesity. Our aim was to compare functional scores and flexion post-TKA in each class of obesity as per WHO classification against a matched control group of nonobese patients.MethodsRecords of 885 consecutive primary TKA patients (919 knees) operated by a single surgeon were reviewed. The first 35 knees in each class I, class II and class III obesity group during the study period were then matched with a similar number of knees in nonobese TKA patients during the same period. Functional scores recorded pre- and postoperatively at 3 months and 1 year were Western Ontario and McMaster Osteoarthritis Index (WOMAC), Short-Form Health Survey (SF-12) score, and Knee Society Score (KSS).ResultsThere was no difference in any parameter between the class I obese and matched nonobese at any assessment point. In the class II obese, as compared to the nonobese, there was no difference in any parameter preoperatively and 3 months postoperatively. However, 1 year postoperatively, the SF-12 physical subscore was lower in the class II obese than the nonobese (44.7 vs. 48.6, p = 0.047) and the WOMAC score was significantly higher (15.8 vs. 9.7, p = 0.04). In the class III obese, the WOMAC score was significantly higher than the nonobese (58.1 vs. 44.3, p < 0.001 preoperatively; 15.7 vs. 8.1, p = 0.005 at 1 year) and KSS was significantly lower (83.5 vs. 96.5, p = 0.049 preoperatively; 172 vs. 185; p = 0.003 at 1 year). Knee flexion was significantly lower in the class III obese than the nonobese (95 vs. 113; p < 0.001 preoperatively; 120 vs. 127; p = 0.002 at 1 year).ConclusionsThe class I obese can expect good early and late functional recovery as the nonobese. The class II obese can expect comparable early functional recovery as the nonobese but their late function may be lesser. The class III obese would have poorer functional scores and lesser knee flexion postoperatively compared to the nonobese. However, compared to their own preoperative status, there is definite improvement in function and knee flexion.
Background:The low contact stress rotating platform (LCS RP) knee (DePuy Orthopedics, Inc, Warsaw, Indiana), in use for last four decades in Western population, is reported to have a survival of more than 95% at 15 to 20 years. The reported Indian experience of this knee is limited to 5 years. Our aim was to report the clinical and radiological results of the LCS RP TKA design in the Indian population with a minimum followup of 10 years.Materials and Methods:Fifty-five LCS knees (45 patients) operated between February 1997 and October 2001 were evaluated retrospectively. LCS design was generally selected if the patient was young (≤65 years of age), active and had no severe deformity. There were 40 female (88.9%) and 5 male (11.1%) patients; 47 knees had osteoarthritis (85.5%) and 8 knees had rheumatoid arthritis (14.5%). Knee Society Scores (KSS) and outcome questionnaire were filled at followup and radiographs were analyzed using Knee Society radiographic evaluation and scoring system.Results:Of 45 patients (55 knees) enrolled, 37 patients (44 knees; 80%) were available for followup at 10 years. Average age was 59.6 years (range 40 to 77). Minimum followup was 10 years (average 12.3 years; range 10 to 15.3 years.). Three knees (6.8%) had been revised, one each for aseptic loosening, bearing dislocation and infection. Mean preoperative KSS of 33 improved to 91 postoperatively. Mean preoperative functional score of 45 improved to 76 postoperatively. Mean preoperative flexion of 113° (90°-140°) reduced to 102° (80°-135°) postoperatively. Erratic femoral rollback and tighter flexion gap to prevent spin out are the probable factors for decreased postoperative range of motion. Five (12%) patients could sit cross-legged and sit on the floor. Anterior knee pain was present in 4.6% (2/44 knees). The survival was 93.2% at 12.3 years. One patient (1.8%) had spin-out of the rotating bearing. No knee had osteolysis or progressive radiolucent lines on X-rays.Conclusion:LCS implant has given good survival (93.2% at 12.3 years) with low rates of spin-out and anterior knee pain and no incidence of osteolysis. Limited flexion post surgery (104°) with only 12% managing to sit cross legged on the floor is a drawback.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.